Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dexborneol SCHEMBL115722 | 1.00 | EPHX2 (0.41) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| Dexborneol SCHEMBL2784798 | 1.00 | EPHX2 (0.41) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| Dexborneol SCHEMBL56715 | 1.00 | EPHX2 (0.41) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| Borneol SCHEMBL9303303 | 1.00 | EPHX2 (0.41) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| Dexborneol SCHEMBL17746906 | 1.00 | EPHX2 (0.41) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| Dexborneol SCHEMBL1325921 | 1.00 | EPHX2 (0.41) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| Dexborneol SCHEMBL23849409 | 1.00 | EPHX2 (0.41) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| Dexborneol SCHEMBL56713 | 1.00 | EPHX2 (0.41) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| Borneol SCHEMBL20576251 | 1.00 | EPHX2 (0.41) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| Dexborneol SCHEMBL20576252 | 1.00 | EPHX2 (0.41) | EPHX2MAPTMAPK1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104604-A1 | SOLID FRAGRANCE COMPOSITION | FIRMENICH SA (CH) | 2026-05-21 | — | — | WO | claimed |
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| WO-2024213536-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| US-20240239994-A1 | COMPOSITIONS TO LIMIT, REDUCE OR ELIMINATE MALODOURS ASSOCIATED WITH PLASTIC MATERIALS | FIRMENICH SA (CH) | 2024-07-18 | — | — | US | claimed |
| EP-4319716-A1 | COMPOSITIONS TO LIMIT, REDUCE OR ELIMINATE MALODOURS ASSOCIATED WITH PLASTIC MATERIALS | Firmenich SA (CH) | 2024-02-14 | — | — | EP | claimed |
| US-20230399590-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | SA, GIVAUDAN (CH) | 2023-12-14 | — | — | US | claimed |
| US-20230151305-A1 | FRAGRANCE COMPOSITION | SA, GIVAUDAN (CH) | 2023-05-18 | — | — | US | claimed |
| CN-115551986-A | Fragrance composition | 奇华顿股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| WO-2022253712-A1 | COMPOSITIONS TO LIMIT, REDUCE OR ELIMINATE MALODOURS ASSOCIATED WITH PLASTIC MATERIALS | FIRMENICH SA (CH) | 2022-12-08 | — | — | WO | claimed |
| CN-114513960-A | Antimicrobial composition for animal feed | 塔明克私人有限公司 | 2022-05-17 | — | — | CN | claimed |
| EP-2555763-A1 | VIRAL INHIBITOR COMPOSITIONS FOR IN VIVO THERAPEUTIC USE COMPRISING A COMBINATION OF (-) -CARVONE, GERANIOL AND A FURTHER ESSENTIAL OIL COMPONENT | Cesa Alliance S.A. (LU) | 2013-02-13 | — | — | EP | claimed |
| WO-2011117424-A1 | VIRAL INHIBITOR COMPOSITIONS FOR IN VIVO THERAPEUTIC USE COMPRISING A COMBINATION OF (-) -CARVONE, GERANIOL AND A FURTHER ESSENTIAL OIL COMPONENT | CESA ALLIANCE S.A. (LU) | 2011-09-29 | — | — | WO | claimed |
| WO-2026104604-A1 | SOLID FRAGRANCE COMPOSITION | FIRMENICH SA (CH) | 2026-05-21 | — | — | WO | disclosed |
| EP-4214303-B1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2026-05-06 | — | — | EP | disclosed |
| WO-2026087780-A1 | CORE-SHELL MICROCAPSULES | FIRMENICH SA (CH) | 2026-04-30 | — | — | WO | disclosed |
| EP-4727358-A1 | MONOTERPENOID AND DITERPENOID-BASED HERBICIDAL COMPOSITION | Bio-Blaster LLC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20060058547-A1 | Process for producing salicylic esters | KAO CORPORATION (JP) | 2006-03-16 | — | — | US | disclosed |
| EP-1634571-A1 | Transesterification process for producing salicylic esters used in perfumes | KAO CORPORATION (JP) | 2006-03-15 | — | — | EP | disclosed |
| CN-1746151-A | Process for producing salicylic esters | KAO CORP (JP) | 2006-03-15 | — | — | CN | disclosed |
| WO-1991018890-A1 | BICYCLIC CHIRAL COMPOUNDS | THE BRITISH PETROLEUM COMPANY PLC (GB) | 1991-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | EPHX2 337/4885MAPT 4309/4885MAPK1 3642/4885 |
| US-20060058547-A1 | Process for producing salicylic esters | NOTUM, FASN, AGPS | EPHX2 583/4885MAPT 3003/4885MAPK1 2542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.